Latest News & Updates

Breaking News

  • 3 hours ago

  • Pharma Now Editorial Team

Novartis Presents Actinium-Based RLT Phase 1 Data at ASCO 2026 Alongside Pluvicto and Pipeline Updates
Breaking News
Capricor Therapeutics Advances Deramiocel BLA Review Ahead of August 2026 PDUFA Date

Pharma Now Editorial Team

Other trending news you may like to read

Novartis Presents Actinium-Based RLT Phase 1 Data at ASCO 2026 Alongside Pluvicto and Pipeline Updates

Novartis presents Phase 1 actinium-225 RLT and Pluvicto data at ASCO 2026, raising new manufacturing complexity for radiopharmaceutical facilities.

Pharma Now Editorial Team

Pharma Now

Capricor Therapeutics Advances Deramiocel BLA Review Ahead of August 2026 PDUFA Date

Capricor's deramiocel faces an August 22, 2026 PDUFA date as HOPE-3 phase 3 data strengthen the DMD BLA case.

Pharma Now Editorial Team

Pharma Now

Infex Therapeutics Achieves Positive Phase IIa Results for RESP-X in Pseudomonas-Colonised Bronchiectasis Patients

Infex Therapeutics reports positive Phase IIa data for RESP-X mAb in NCFB, supporting quarterly dosing and Phase III advancement.

Pharma Now Editorial Team

Pharma Now

QIAGEN Signs AI Drug Discovery Deal with NVIDIA Integrating BioNeMo Platform

QIAGEN and NVIDIA integrate BioNeMo AI platform with biomedical knowledge bases to accelerate drug discovery and compress early R&D timelines.

Pharma Now Editorial Team

Pharma Now